Cargando…
Urinary Prostaglandin E(2) Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai
Pancreatic cancer has been increasing in importance in Shanghai over the last four decades. The etiology of the disease is still unclear. Evidence suggests that the COX-2 pathway, an important component of inflammation, may be involved in the disease. We aimed to evaluate the association between uri...
Autores principales: | Zhao, Jing, Wang, Jing, Du, Jinfeng, Xu, Hongli, Zhang, Wei, Ni, Quan-Xing, Yu, Herbert, Risch, Harvey A., Gao, Yu-Tang, Gao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332509/ https://www.ncbi.nlm.nih.gov/pubmed/25679523 http://dx.doi.org/10.1371/journal.pone.0118004 |
Ejemplares similares
-
Plasma Metabolite Biomarkers
for the Detection of
Pancreatic Cancer
por: Xie, Guoxiang, et al.
Publicado: (2014) -
Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population
por: Xu, Hong-Li, et al.
Publicado: (2014) -
Association of urinary prostaglandin E2 metabolite and mortality among adults
por: Wen, Wanqing, et al.
Publicado: (2022) -
Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome
por: Peng, Xiaoyan, et al.
Publicado: (2017) -
Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma
por: Kawamoto, Hironori, et al.
Publicado: (2019)